Dr Danielle Burns

She has a strong understanding of global patent and regulatory exclusivities (including data and market exclusivities) and has facilitated entry of several biopharmaceuticals (including antibodies and antisense molecules), diagnostics, cellular therapeutics (including CAR-T cells), vaccines, and agricultural products (including transgenic plants) to market.

Danielle is involved in the preparation and prosecution of patent applications globally; patent due diligence; and provides patentability, infringement, clearance, and validity opinions. Danielle has also been involved in opposition and litigation disputes involving multiple stakeholders, with significant experience in Biologics Price Competition and Innovation Act (BPCIA) litigation.

Danielle has a diverse client base – working with several local and overseas biotech companies, including small to medium entities, big pharmaceutical companies and generics companies as well as academic institutions to strategically protect their intellectual property and facilitate market entry.

Danielle also brings valuable industry experience, having worked as a postdoctoral scientist at BIO21, where she was involved in the expression and purification of proteins involved in Influenza-specific viral immunity. She graduated from The University of Melbourne with a BSc (Hons) majoring in Biochemistry and Immunology.

Danielle went on to complete a PhD in Immunology at The University of Melbourne where she examined how natural variation in genes that control immunity can lead to substantial differences in antiviral immune responses.

Danielle also lectures at The University of Melbourne on Fundamentals of Patent Drafting.